Medication Assisted Treatment (MAT) Buprenorphine, Norbuprenorphine, and Naloxone MS Confirmation, Urine
Also known as: Opioid Use Disorder, Suboxone™ MAT, Suboxone™ MAT, Opioid Use Disorder, Buprenorphine/Norbuprenorphine, Naloxone
Use
Detect and confirm presence of prescribed and illicit drugs for monitoring Suboxone™/buprenorphine medication assisted treatment (MAT). Please note: This testing is designed specifically for monitoring patients who are on Suboxone™/buprenorphine only. This testing should not be used for monitoring chronic pain patients (medical drug monitoring) or methadone medication assisted treatment.
Special Instructions
This profile is designed exclusively for Suboxone™/buprenorphine medication-assisted treatment. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs. Additional time may be required for confirmatory or reflex testing, and testing schedules may vary.
Limitations
The performance characteristics of some components of this panel were determined by Labcorp and have not been cleared or approved by the FDA. This testing should not be used for other medication monitoring such as chronic pain management or methadone treatment.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 19150-2
- 3414-0
- 58360-9
- 58361-7
- 77207-9
Result Turnaround Time
4-7 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
10 mL
Minimum Volume
3 mL
Container
Plastic urine container or transfer tube without preservative
Storage Instructions
Submission/transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.
Causes for Rejection
Urine from preservative tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 6 weeks |